Orange Book product · Brand (NDA)
EVEKEO ODT
AMPHETAMINE SULFATE
At a glance
Apr 16, 2021
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 16, 2021
5 yr 3 mo ago
Today
Patent 10441554 expires
Listed drug product patent expiration.
Mar 10, 2037
in 10 yr 11 mo
Patent 11160772 expires
Listed drug product patent expiration.
Mar 10, 2037
in 10 yr 11 mo
Pharmaceutical detail
Active ingredient
AMPHETAMINE SULFATE
Strength
2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
TE code
Not listed
Application
NDA 209905
Product number
005
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2021AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213852 · RHODES PHARMS
- 2021AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 212186 · GLENMARK PHARMS LTD
- 2021AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 214574 · SUN PHARM INDS INC
- 2021AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213583 · SPECGX LLC
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213720 · ALKEM LABS LTD
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213980 · EPIC PHARMA LLC
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213763 · INGENUS PHARMS LLC
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 213898 · DR REDDYS LABS SA
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 212901 · SENORES PHARMS
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 211861 · PRINSTON INC
- 2020AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 212582 · SANALUZ
- 2019AMPHETAMINE SULFATEGeneric (ANDA)
ANDA 212919 · BIONPHARMA
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10441554 | Mar 10, 2037 | in 10 yr 11 mo | Product |
| 11160772 | Mar 10, 2037 | in 10 yr 11 mo | Product |

